MelanomaSymptoms, Doctors, Treatments, Advances & More
Learn About Melanoma
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Rockefeller Outpatient Pavilion
Michael Postow is a Dermatologist practicing medicine in New York, New York. Dr. Postow is rated as an Elite provider by MediFind in the treatment of Melanoma. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Melanoma, Uveal Melanoma, Metastatic Uveal Melanoma, Sinus Cancer, and Liver Embolization.
Northwell Health Center For Advanced Medicine, RJ Zuckerberg Cancer Center
Richard Carvajal is an Oncologist practicing medicine in Lake Success, New York. Dr. Carvajal is rated as an Elite provider by MediFind in the treatment of Melanoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Metastatic Uveal Melanoma, Uveal Melanoma, Melanoma of the Eye, Melanoma, and Tissue Biopsy. Dr. Carvajal is board certified in American Board Of Internal Medicine/Medical Oncology.
Penn Endocrine And Oncologic Surgery Perelman 3rd Floor
Giorgos Karakousis is a General Surgeon practicing medicine in Philadelphia, Pennsylvania. Dr. Karakousis is rated as an Elite provider by MediFind in the treatment of Melanoma. He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Adult Soft Tissue Sarcoma, Lymphadenectomy, and Gastrectomy. Dr. Karakousis is board certified in Surgery, 2008. Dr. Karakousis is currently accepting new patients.
Background: A type of drug called monoclonal antibody immune checkpoint inhibitors are often used in cancer treatment. These drugs help the body s immune system fight cancer by blocking proteins that cause cancer cells to grow. One of these drugs (atezolizumab) is approved to treat certain cancers. Researchers want to find out if lower doses of this drug might provide the same benefit with fewer adverse effec...
Summary: Phase IIa study of HX009+ IN10018 in combination with or without standard chemotherapy in patients with advanced solid tumours including biliary tract malignancies and malignant melanoma